Please try another search
NatureWise Biotech & Medicals Corporation reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 66.36 million compared to TWD 114.5 million a year ago. Net income was TWD 3.39 million compared to TWD 17.5 million a year ago. Basic earnings per share from continuing operations was TWD 0.07 compared to TWD 0.35 a year ago. Diluted earnings per share from continuing operations was TWD 0.07 compared to TWD 0.35 a year ago.
Period Ending: | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Total Revenue | 33.18 | 33.18 | 57.05 | 57.05 |
Gross Profit | 18.03 | 18.03 | 31.45 | 31.45 |
Operating Income | 0.43 | 0.43 | 5.28 | 5.28 |
Net Income | 1.7 | 1.7 | 6.26 | 6.26 |
Period Ending: | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Total Assets | 685.62 | 685.62 | 692.6 | 692.6 |
Total Liabilities | 62.34 | 62.34 | 51.09 | 51.09 |
Total Equity | 623.28 | 623.28 | 641.51 | 641.51 |
Period Ending: | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 13.11 | 13.11 | -3.58 | -3.58 |
Cash From Investing Activities | -13.59 | -13.59 | 0.235 | 0.235 |
Cash From Financing Activities | -1 | -1 | -8.38 | -8.38 |
Net Change in Cash | -1.68 | -1.68 | -11.78 | -11.78 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review